How to Help Your Patients Save Money on Ubrelvy: A Provider's Guide to Savings Programs

For many migraine patients, cost is the primary barrier to accessing Ubrelvy — not lack of clinical indication. With a wholesale list price of $1,139.09 per 30-day supply and no generic available until at least 2035, patients who don't have optimal insurance coverage may face retail bills over $1,300 for 10 tablets.

As a provider, understanding and actively communicating cost-reduction resources can dramatically improve medication adherence and patient outcomes. This guide gives you everything you need to counsel patients on Ubrelvy cost and connect them to the right programs.

The Cost Landscape for Ubrelvy in 2026

Here is the current cost picture for Ubrelvy that will shape what your patients encounter:

WAC (list price): $1,139.09 per 30-day supply as of January 2026

Retail cash price: $1,300–$1,450 for 10 tablets (50 mg or 100 mg) without insurance

With GoodRx / SingleCare: ~$970–$1,050 for 10 tablets (significant savings for cash-paying patients)

Generic availability: None expected until at least 2035 (patent protection)

Insurance tier: Most plans place Ubrelvy at Tier 3 or non-preferred with prior authorization and/or step therapy requirements

Program 1: Ubrelvy Complete Savings Card — Most Important for Commercial Plans

The AbbVie Ubrelvy Complete Savings Card is the cornerstone savings program for commercially insured patients. It should be recommended at every eligible prescribing encounter.

Patient out-of-pocket: As little as $0 per monthly prescription fill

Annual maximum: $7,000 in savings per calendar year

Maximum uses: Up to 13 prescription fills

PA pending bridge: Up to 2 months of free fills for commercially insured patients while prior authorization is under review

Coverage not yet established: Up to 4 one-month fills at no charge if insurer has not yet established a review process

Eligibility restrictions: Commercial insurance only. Not valid for Medicare, Medicaid, VA, TRICARE, or government plans. Not valid for cash-paying patients.

Patient enrollment: Visit ubrelvy.com/savings or call 1-844-577-6239. Online registration takes 5–10 minutes and produces an immediate savings card to use at the pharmacy.

Program 2: myAbbVie Assist — For Uninsured and Underinsured Patients

For patients without adequate insurance coverage, the myAbbVie Assist patient assistance program can provide Ubrelvy free of charge for up to 12 months for qualifying patients.

Eligibility criteria: U.S. resident, valid Ubrelvy prescription, limited or no insurance coverage, meets income requirements (reviewed case-by-case)

Duration: Up to 12 months; reapplication permitted

Application: Patients can apply online or your staff can assist. GoodRx (goodrx.com/ubrelvy) provides direct links to this program.

Action for your practice: Post a note in your patient education materials or establish a staff workflow to identify uninsured patients and refer them to myAbbVie Assist at the point of prescribing.

Program 3: AbbVie Samples for Bridge Therapy

AbbVie distributes Ubrelvy samples to healthcare providers. Samples serve two key purposes in cost management:

Bridge therapy during PA processing — patients can use samples while waiting for prior authorization

Trial before commitment — let patients try Ubrelvy before navigating the cost/insurance process

Contact your AbbVie sales representative to maintain sample inventory. The On-the-Go Pack format is practical — each tablet is individually sealed and patients can keep one or two in their purse or pocket for immediate use when a migraine starts.

Optimizing the Prior Authorization Process to Unlock Insurance Coverage

A well-documented PA is often the single most impactful action for getting a patient's insurance to cover Ubrelvy at a manageable copay. Key elements of a strong Ubrelvy PA:

Clear migraine diagnosis (ICD-10 code G43.x) in the medical record

Documentation of trial and failure of 2+ triptans (name, dose, duration, reason for failure — insufficient efficacy or intolerance)

If triptans are contraindicated: explicit documentation of cardiovascular or other contraindication

Description of migraine impact on patient's functional capacity and quality of life

Letter of medical necessity if required by the payer

Pro tip: Use a standardized PA template in your EHR to ensure all required elements are captured efficiently. Submit proactively at the time of prescribing — not after a denial — to avoid treatment gaps.

Discount Coupons for Cash-Paying Patients (GoodRx and SingleCare)

For patients who are cash-paying (not using insurance) and don't qualify for the AbbVie savings card, discount coupons from GoodRx and SingleCare can provide meaningful savings:

GoodRx: ~$1,048 for 10 tablets of 50 mg at participating pharmacies (vs. ~$1,317 retail)

SingleCare: ~$970 for 10 tablets at Walgreens

While these represent a ~25–35% reduction from retail, the absolute cost remains high ($970–$1,050/10 tablets). Steer eligible patients toward the Ubrelvy savings card or patient assistance program first, as these offer far greater savings.

Summary: Provider Cost-Counseling Checklist for Ubrelvy

Commercial insurance → Ubrelvy Complete Savings Card (ubrelvy.com/savings, 1-844-577-6239)

PA pending → Savings card bridge fills (up to 2 months free while under review)

Uninsured/underinsured + low income → myAbbVie Assist (apply online or via your office)

PA optimization → Submit proactively with triptan failure documentation

Bridge therapy → Keep samples on hand from AbbVie rep

Cash pay / savings card ineligible → GoodRx or SingleCare coupons (~$970–$1,050/10 tablets)

For help getting patients to the pharmacies that actually have Ubrelvy in stock — and reducing prescription abandonment at the fill stage — recommend medfinder for providers. medfinder calls pharmacies near your patient and texts them results, reducing the practical barrier of locating a stocked pharmacy.

For companion guidance on the availability side, see: How to Help Your Patients Find Ubrelvy in Stock: A Provider's Guide.